Condensed Statement of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Series A Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance at Beginning at Dec. 31, 2020	$ 776	$ 7,935	$ 28	$ 14,166	$ (21,353)
Balance at Beginning (in Shares) at Dec. 31, 2020		6,687,475	37,366,865
Issuance of common stock upon exercise of stock options	570		$ 2	568
Issuance of common stock upon exercise of stock options, shares			690,551
Share-based compensation expense	402			402
Net loss	(2,432)				(2,432)
Balance at Ending at Mar. 31, 2021	(684)	$ 7,935	$ 30	15,136	(23,785)
Balance at Ending (in Shares) at Mar. 31, 2021		6,687,475	38,057,416
Balance at Beginning at Dec. 31, 2020	776	$ 7,935	$ 28	14,166	(21,353)
Balance at Beginning (in Shares) at Dec. 31, 2020		6,687,475	37,366,865
Net loss	(7,515)
Balance at Ending at Jun. 30, 2021	102,911		$ 45	131,734	(28,868)
Balance at Ending (in Shares) at Jun. 30, 2021			52,755,981
Balance at Beginning at Mar. 31, 2021	(684)	$ 7,935	$ 30	15,136	(23,785)
Balance at Beginning (in Shares) at Mar. 31, 2021		6,687,475	38,057,416
Issuance of common stock upon exercise of stock options	193			193
Issuance of common stock upon exercise of stock options, shares			272,082
Vesting of restricted stock awards, shares			5,866
Share-based compensation expense	875			875
Issuance of common stock from initial public offering, net of issuance costs and underwriting discount of $10.6 million, shares			6,953,125
Issuance of common stock from initial public offering, net of issuance costs and underwriting discount of $10.6 million	107,610		$ 7	107,603
Issuance of common stock upon net exercise of warrants, shares			621,570
Issuance of common stock upon net exercise of warrants			$ 1	(1)
Conversion of convertible preferred stock and accrued dividends on convertible preferred stock into common stock, shares		(6,687,475)	6,845,922
Conversion of convertible preferred stock and accrued dividends on convertible preferred stock into common stock		$ (7,935)	$ 7	7,928
Net loss	(5,083)				(5,083)
Balance at Ending at Jun. 30, 2021	102,911		$ 45	131,734	(28,868)
Balance at Ending (in Shares) at Jun. 30, 2021			52,755,981
Balance at Beginning at Dec. 31, 2021	93,073		$ 45	134,933	(41,905)
Balance at Beginning (in Shares) at Dec. 31, 2021			54,181,082
Issuance of common stock upon exercise of stock options	1,372		$ 1	1,371
Issuance of common stock upon exercise of stock options, shares			1,097,860
Share-based compensation expense	1,409			1,409
Net loss	(9,036)				(9,036)
Balance at Ending at Mar. 31, 2022	86,818		$ 46	137,713	(50,941)
Balance at Ending (in Shares) at Mar. 31, 2022			55,278,942
Balance at Beginning at Dec. 31, 2021	93,073		$ 45	134,933	(41,905)
Balance at Beginning (in Shares) at Dec. 31, 2021			54,181,082
Net loss	(26,270)
Balance at Ending at Jun. 30, 2022	71,712		$ 46	139,841	(68,175)
Balance at Ending (in Shares) at Jun. 30, 2022			55,391,309
Balance at Beginning at Mar. 31, 2022	86,818		$ 46	137,713	(50,941)
Balance at Beginning (in Shares) at Mar. 31, 2022			55,278,942
Issuance of common stock upon exercise of stock options	165			165
Issuance of common stock upon exercise of stock options, shares			112,367
Share-based compensation expense	1,963			1,963
Net loss	(17,234)				(17,234)
Balance at Ending at Jun. 30, 2022	$ 71,712		$ 46	$ 139,841	$ (68,175)
Balance at Ending (in Shares) at Jun. 30, 2022			55,391,309